These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22538330)

  • 1. Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study.
    Swedberg K; Zannad F; McMurray JJ; Krum H; van Veldhuisen DJ; Shi H; Vincent J; Pitt B;
    J Am Coll Cardiol; 2012 May; 59(18):1598-603. PubMed ID: 22538330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.
    Rossignol P; Girerd N; Bakris G; Vardeny O; Claggett B; McMurray JJV; Swedberg K; Krum H; van Veldhuisen DJ; Shi H; Spanyers S; Vincent J; Fay R; Lamiral Z; Solomon SD; Zannad F; Pitt B
    Eur J Heart Fail; 2017 Jun; 19(6):792-799. PubMed ID: 27868385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial.
    Girerd N; Collier T; Pocock S; Krum H; McMurray JJ; Swedberg K; Van Veldhuisen DJ; Vincent J; Pitt B; Zannad F
    Eur Heart J; 2015 Sep; 36(34):2310-7. PubMed ID: 26093641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial.
    Olivier A; Pitt B; Girerd N; Lamiral Z; Machu JL; McMurray JJV; Swedberg K; van Veldhuisen DJ; Collier TJ; Pocock SJ; Rossignol P; Zannad F; Pizard A
    Eur J Heart Fail; 2017 Sep; 19(9):1186-1197. PubMed ID: 28303624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study.
    Chin KL; Collier TJ; Pitt B; McMurray JJ; Swedberg K; van Veldhuisen DJ; Pocock SJ; Vincent J; Turgonyi E; Zannad F; Krum H;
    Eur J Heart Fail; 2016 Sep; 18(9):1175-81. PubMed ID: 26833642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial.
    Collier TJ; Pocock SJ; McMurray JJ; Zannad F; Krum H; van Veldhuisen DJ; Swedberg K; Shi H; Vincent J; Pitt B
    Eur Heart J; 2013 Sep; 34(36):2823-9. PubMed ID: 23864130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).
    Zannad F; McMurray JJ; Drexler H; Krum H; van Veldhuisen DJ; Swedberg K; Shi H; Vincent J; Pitt B
    Eur J Heart Fail; 2010 Jun; 12(6):617-22. PubMed ID: 20388647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate.
    Chin KL; Collier T; Pocock S; Pitt B; McMurray JJV; van Veldhuisen DJ; Swedberg K; Vincent J; Zannad F; Liew D
    Clin Res Cardiol; 2019 Jul; 108(7):806-814. PubMed ID: 30604047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations.
    Rogers JK; McMurray JJ; Pocock SJ; Zannad F; Krum H; van Veldhuisen DJ; Swedberg K; Shi H; Vincent J; Pitt B
    Circulation; 2012 Nov; 126(19):2317-23. PubMed ID: 23042980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms.
    Dhillon S
    Drugs; 2013 Sep; 73(13):1451-62. PubMed ID: 23881669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
    Rossignol P; Dobre D; McMurray JJ; Swedberg K; Krum H; van Veldhuisen DJ; Shi H; Messig M; Vincent J; Girerd N; Bakris G; Pitt B; Zannad F
    Circ Heart Fail; 2014 Jan; 7(1):51-8. PubMed ID: 24297687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF.
    Naser N; Durak-Nalbantic A; Sabanovic-Bajramovic N; Karic A
    Med Arch; 2023 Apr; 77(2):105-111. PubMed ID: 37260796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
    Preiss D; van Veldhuisen DJ; Sattar N; Krum H; Swedberg K; Shi H; Vincent J; Pocock SJ; Pitt B; Zannad F; McMurray JJ
    Eur J Heart Fail; 2012 Aug; 14(8):909-15. PubMed ID: 22611047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms.
    Lee D; Wilson K; Akehurst R; Cowie MR; Zannad F; Krum H; van Veldhuisen DJ; Vincent J; Pitt B; McMurray JJ;
    Heart; 2014 Nov; 100(21):1681-7. PubMed ID: 24993605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
    Krum H; Shi H; Pitt B; McMurray J; Swedberg K; van Veldhuisen DJ; Vincent J; Pocock S; Zannad F;
    Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
    Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC
    J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).
    Cannon JA; Collier TJ; Shen L; Swedberg K; Krum H; Van Veldhuisen DJ; Vincent J; Pocock SJ; Pitt B; Zannad F; McMurray JJ
    Eur J Heart Fail; 2015 Jul; 17(7):707-16. PubMed ID: 26139584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study.
    Montalescot G; Pitt B; Lopez de Sa E; Hamm CW; Flather M; Verheugt F; Shi H; Turgonyi E; Orri M; Vincent J; Zannad F; ;
    Eur Heart J; 2014 Sep; 35(34):2295-302. PubMed ID: 24780614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eplerenone in patients with systolic heart failure and mild symptoms.
    Zannad F; McMurray JJ; Krum H; van Veldhuisen DJ; Swedberg K; Shi H; Vincent J; Pocock SJ; Pitt B;
    N Engl J Med; 2011 Jan; 364(1):11-21. PubMed ID: 21073363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.